ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 159 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2018. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,769,221 | -28.9% | 77,678 | -8.1% | 0.00% | -33.3% |
| Q2 2023 | $3,897,293 | +16.4% | 84,485 | +1.2% | 0.01% | +20.0% |
| Q1 2023 | $3,348,470 | -14.7% | 83,503 | -1.5% | 0.01% | -16.7% |
| Q4 2022 | $3,927,626 | +13.3% | 84,775 | +1.3% | 0.01% | 0.0% |
| Q3 2022 | $3,466,000 | -33.7% | 83,692 | -4.5% | 0.01% | -25.0% |
| Q2 2022 | $5,229,000 | -16.2% | 87,651 | +2.0% | 0.01% | 0.0% |
| Q1 2022 | $6,242,000 | -20.1% | 85,959 | -7.5% | 0.01% | -11.1% |
| Q4 2021 | $7,811,000 | -22.1% | 92,886 | -16.4% | 0.01% | -30.8% |
| Q3 2021 | $10,023,000 | -10.4% | 111,128 | -5.3% | 0.01% | -7.1% |
| Q2 2021 | $11,189,000 | -3.3% | 117,351 | +15.4% | 0.01% | -6.7% |
| Q1 2021 | $11,576,000 | -16.8% | 101,668 | +1.2% | 0.02% | -21.1% |
| Q4 2020 | $13,910,000 | +82.4% | 100,487 | +8.3% | 0.02% | +58.3% |
| Q3 2020 | $7,628,000 | +14.0% | 92,812 | +8.5% | 0.01% | 0.0% |
| Q2 2020 | $6,689,000 | +81.3% | 85,520 | +3.0% | 0.01% | +50.0% |
| Q1 2020 | $3,690,000 | +3.5% | 83,055 | -0.5% | 0.01% | +33.3% |
| Q4 2019 | $3,565,000 | -2.1% | 83,466 | -2.0% | 0.01% | -14.3% |
| Q3 2019 | $3,643,000 | -31.8% | 85,153 | +1.2% | 0.01% | -36.4% |
| Q2 2019 | $5,343,000 | -4.3% | 84,135 | +4.5% | 0.01% | 0.0% |
| Q1 2019 | $5,583,000 | +71.7% | 80,494 | +7.6% | 0.01% | +57.1% |
| Q4 2018 | $3,252,000 | -40.8% | 74,783 | +4.0% | 0.01% | -36.4% |
| Q3 2018 | $5,491,000 | -0.7% | 71,932 | -0.0% | 0.01% | -8.3% |
| Q2 2018 | $5,531,000 | +59.9% | 71,956 | +6.0% | 0.01% | +71.4% |
| Q1 2018 | $3,460,000 | +19.6% | 67,861 | +8.8% | 0.01% | +16.7% |
| Q4 2017 | $2,894,000 | -14.2% | 62,396 | -1.5% | 0.01% | -14.3% |
| Q3 2017 | $3,374,000 | -22.5% | 63,344 | -9.6% | 0.01% | -22.2% |
| Q2 2017 | $4,354,000 | -15.3% | 70,106 | -7.6% | 0.01% | -10.0% |
| Q1 2017 | $5,141,000 | -1.5% | 75,845 | +2.2% | 0.01% | -9.1% |
| Q4 2016 | $5,220,000 | -3.5% | 74,245 | -2.6% | 0.01% | 0.0% |
| Q3 2016 | $5,409,000 | +46.4% | 76,245 | +0.9% | 0.01% | +37.5% |
| Q2 2016 | $3,695,000 | -28.5% | 75,545 | -7.5% | 0.01% | -27.3% |
| Q1 2016 | $5,171,000 | -35.2% | 81,671 | +14.8% | 0.01% | -42.1% |
| Q4 2015 | $7,984,000 | +18.3% | 71,172 | +1.6% | 0.02% | +5.6% |
| Q3 2015 | $6,749,000 | +0.5% | 70,072 | +6.9% | 0.02% | +12.5% |
| Q2 2015 | $6,714,000 | +665.6% | 65,572 | +364.2% | 0.02% | +700.0% |
| Q1 2015 | $877,000 | +53.3% | 14,125 | +8.4% | 0.00% | +100.0% |
| Q4 2014 | $572,000 | -22.1% | 13,025 | +0.4% | 0.00% | -50.0% |
| Q3 2014 | $734,000 | +35.2% | 12,970 | +7.2% | 0.00% | +100.0% |
| Q2 2014 | $543,000 | -7.5% | 12,100 | +0.8% | 0.00% | -50.0% |
| Q1 2014 | $587,000 | – | 12,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 38,100 | $2,928,000 | 1.67% |
| Opaleye Management Inc. | 80,000 | $6,149,000 | 1.59% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 410,000 | $31,517,000 | 1.06% |
| Opus Point Partners Management, LLC | 6,311 | $485,000 | 1.05% |
| SECTOR GAMMA AS | 68,015 | $5,228,000 | 0.87% |
| Capital Impact Advisors, LLC | 27,074 | $2,061,000 | 0.76% |
| FORTALEZA ASSET MANAGEMENT INC/ | 1,130 | $87,000 | 0.71% |
| CAPITAL INTERNATIONAL LTD /CA/ | 46,957 | $3,610,000 | 0.63% |
| Virtus ETF Advisers LLC | 8,794 | $676,000 | 0.60% |
| Rock Springs Capital Management LP | 200,000 | $15,374,000 | 0.59% |